CATABASIS PHARMACEUTICALS INC Underwriting Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated February 6, 2019, by and between the Company and Oppenheimer & Co. Inc
Underwriting Agreements
CATABASIS PHARMACEUTICALS INC
Biotechnology
NY
2019
Underwriting Agreement, dated January 30, 2024, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C
Underwriting Agreements
CATABASIS PHARMACEUTICALS INC
2024
Underwriting Agreement, dated October 11, 2023, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C
Underwriting Agreements
CATABASIS PHARMACEUTICALS INC
2023
Underwriting Agreement, dated December 15, 2022, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C
Underwriting Agreements
CATABASIS PHARMACEUTICALS INC
Biotechnology
NY
2022
Underwriting Agreement, dated January 30, 2020, by and between the Company and Oppenheimer & Co. Inc
Underwriting Agreements
CATABASIS PHARMACEUTICALS INC
Biotechnology
NY
2020
Underwriting Agreement, dated June 19, 2018, by and between the Company and the Underwriter
Underwriting Agreements
CATABASIS PHARMACEUTICALS INC
Biotechnology
NY
2018
Form of Underwriting Agreement
Underwriting Agreements
CATABASIS PHARMACEUTICALS INC
Biotechnology
NY
2018
Catabasis Pharmaceuticals, Inc. 2,500,000 Shares Common Stock ($0.001 par value per share) Underwriting Agreement
Underwriting Agreements
CATABASIS PHARMACEUTICALS INC
Biotechnology
NY
2016
Catabasis Pharmaceuticals, Inc. Shares Common Stock ($0.001 par value per share) Underwriting Agreement
Underwriting Agreements
CATABASIS PHARMACEUTICALS INC
Biotechnology
NY
2015